A study to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity following single dose subcutaneous or intravenous administration of ABBV‐3373 in healthy subjects
Latest Information Update: 23 Apr 2021
Price :
$35 *
At a glance
- Drugs ABBV 3373 (Primary) ; ABBV 3373 (Primary) ; Prednisone
- Indications Rheumatoid arthritis
- Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
- 23 Apr 2021 New trial record
- 17 Mar 2021 Results presented at the 122nd Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics